Form EFFECT Milestone Pharmaceutical
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 22, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BC.GAME Token $BC Reaches New High, Gains More Than 260% Over the Past Year
- INFRONEER Teams with Accenture to Build New Financial Data and Insights Platform to Advance its Group Management Capabilities in Just Three Months
- Circles, Greyskies, and HCLTech Collaborate in TM Forum Catalyst Program to Accelerate AI-led Autonomous Network Operations
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
